FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Neogen Corporation Stock AnalysisComprehensive stock analysis for Neogen Corporation (NEOG) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisNEOG
NEOG
Neogen Corporation
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
NEOG
Home🔹Stocks🔹Neogen Corporation

Neogen Corporation

🇺🇸NEOG•NASDAQ

Neogen Corporation

🇺🇸NEOG•NASDAQ
Market cap
$2.57B
Sentiment

Your view on NEOG

Mkt Cap
$2.57B
Sentiment
Your view
NEOG
Neogen Corporation
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
NEOG
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Neogen Corporation

Industry
Medical - Devices
Sector
Healthcare
CEO
Mikhael Nassif
Headquarters
620 Lesher Place, Lansing, MI, US
Industry
Medical - Devices
Sector
Healthcare
CEO
Mikhael Nassif
Headquarters
620 Lesher Place, Lansing, MI, US
Description

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety.

The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells.

This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines.

The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances.

Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications.

In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for Neogen Corporation, and the rating behind it. NEOG last traded at $11.78; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Neogen Corporation. Starting points for Neogen Corporation: EPS -$0.04, beta 1.76 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Neogen Corporation. Neogen Corporation does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Neogen Corporation. Trailing twelve-month EPS for Neogen Corporation stands at -$0.04. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Neogen Corporation. Neogen Corporation has reported as a listed company since 1989. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Neogen Corporation valued side by side against its closest peers. Neogen Corporation is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold Neogen Corporation, and how their positions are changing. At a $2.57B market value, institutional positions materially move Neogen Corporation's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by Neogen Corporation executives and directors. Shares of Neogen Corporation have traded between $3.87 and $15.73 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming Neogen Corporation. Neogen Corporation is a $2.57B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming Neogen Corporation. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for Neogen Corporation. Coverage tracks Neogen Corporation within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Peer companies

  • AZTA — Azenta, Inc.
  • BLFS — BioLife Solutions, Inc.
  • CNMD — CONMED Corporation
  • KMTS — KESTRA MEDICAL TECHNOLOGIES, LTD.
  • NTLA — Intellia Therapeutics, Inc.
  • NVCR — NovoCure Limited
  • OPK — OPKO Health, Inc.
  • TLRY — Tilray Brands, Inc.

More Medical - Devices companies

  • GCTK — GlucoTrack, Inc.
  • GEHC — GE HealthCare Technologies Inc.
  • GGNDF — GN Store Nord A/S
  • GKOS — Glaukos Corporation
  • GMED — Globus Medical, Inc.
  • GMVDF — G Medical Innovations Holdings Ltd
  • GNGBF — Getinge AB (publ)
  • GNGBY — Getinge AB (publ)
  • GNNDY — GN Store Nord A/S
  • GTHP — Guided Therapeutics, Inc.
  • HAE — Haemonetics Corporation
  • HMD.AX — HeraMED Limited

ETFs holding Neogen Corporation

  • XHE — State Street SPDR S&P Health Care Equipment ETF (2.01%)
  • NBSM — Neuberger Berman Small-Mid Cap ETF (1.39%)
  • PSCH — Invesco S&P SmallCap Health Care ETF (1.34%)
  • MOO — VanEck Agribusiness ETF (0.60%)
  • SAWS — AAM Sawgrass US Small Cap Quality Growth ETF (0.53%)

News

Latest Market News